These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19357927)

  • 1. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma.
    Chen YL; Jeng YM; Hsu HC; Lai HS; Lee PH; Lai PL; Yuan RH
    Int J Surg; 2013; 11(1):85-91. PubMed ID: 23246869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
    Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
    Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-II mRNA-binding protein 3 expression in effusion cytology: a marker for metastatic adenocarcinoma cells and a potential prognostic indicator in gastric adenocarcinoma.
    Kim HJ; Kim GE; Lee JS; Lee JH; Nam JH; Choi C
    Acta Cytol; 2014; 58(2):167-73. PubMed ID: 24457229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.
    Wei Q; Huang X; Fu B; Liu J; Zhong L; Yang Q; Zhao T
    Int J Clin Exp Pathol; 2015; 8(9):11024-32. PubMed ID: 26617820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
    Lin LJ; Chen LT
    Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
    Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
    Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.
    Li C; Zota V; Woda BA; Rock KL; Fraire AE; Jiang Z; Lu D; Xu B; Dresser K; Lutman CV; Fischer AH
    Mod Pathol; 2007 Dec; 20(12):1263-8. PubMed ID: 17885673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L; Li HG; Xia ZS; Lü J; Peng TS
    Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
    Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of S100P and IMP3 in the cytologic diagnosis of pancreatic adenocarcinoma.
    Ezzat NE; Tahoun NS; Ismail YM
    J Egypt Natl Canc Inst; 2016 Dec; 28(4):229-234. PubMed ID: 27839709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion.
    Pasiliao CC; Chang CW; Sutherland BW; Valdez SM; Schaeffer D; Yapp DT; Ng SS
    BMC Cancer; 2015 Apr; 15():266. PubMed ID: 25886367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
    Trivedi A; Cartun RW; Ligato S
    Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
    Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
    Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
    Lin L; Zhang J; Wang Y; Ju W; Ma Y; Li L; Chen L
    Oncol Lett; 2013 Sep; 6(3):740-744. PubMed ID: 24137402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
    Riener MO; Fritzsche FR; Clavien PA; Pestalozzi BC; Probst-Hensch N; Jochum W; Kristiansen G
    Hum Pathol; 2009 Oct; 40(10):1377-83. PubMed ID: 19467694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.